This isn’t the university’s first innovation in this area. In 2023, the pharmacy introduced locking prescription bottles for narcotics to combat misuse and support the opioid crisis.

A breakout could be on the way, however, as the stock just came into contact with a historically bullish trendline. Per Schaeffer's Senior Quantitative Analyst Rocky White, ADMA has come within ...

As per the latest Enforcement Report of US Food and Drug Administration (USFDA), Aurobindo Pharma USA Inc, a subsidiary of Hyderabad-based drug maker, is recalling over 1 lakh bottles of Cinacalcet ...

If you’re looking to grab some of the best over-ear headphones money can buy, here’s your sign. Originally retailing at ...

ADMA Biologics stock has pulled back to its bullish 200-day moving average Pharmaceutical concern ADMA Biologics Inc (NASDAQ:ADMA) has been consolidating above familiar pressure at the $16 region ...

Elite Pharmaceuticals, with a market capitalization of $531 million, reported a decline in third-quarter revenue for 2024, falling 8% from the previous year. Despite a strong nine-month performance, ...

Despite GILD’s strong fundamentals, 12 of 29 analysts still rate the stock a "hold", while the consensus 12-month price target of $102.86 is soon to be a slim discount to today's perch.

Marksans Pharma - Board Meeting Intimation for To Consider And Approve Unaudited Financial Results For The Quarter And Nine M MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

HDFC Mid-Cap Opportunities Fund (G) 1560.15 1,33,12,972 2.12 HDFC Mid-Cap Opportunities Fund (IDCW) 1560.15 1,33,12,972 2.12 HDFC Mid-Cap Opportunities Fund - Direct ...